STAT News

STAT+: New tumor cases show common gene therapy tool can come with risk

New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and gene therapy researchers in general.

By STAT News

1 min read
STAT+: New tumor cases show common gene therapy tool can come with risk
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights